BEAM Stock Analysis: Buy, Sell, or Hold?
BEAM - Beam Therapeutics Inc. Common Stock
$35.53
1.39 (4.07%)
▲
5d:
+22.39%
30d:
+31.06%
90d:
+44.25%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When BEAM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BEAM is 9.4% above its trading range ($32.47). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BEAM is 9.4% above its trading range ($32.47). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: BEAM is currently trading at $35.53, which is considered extended relative to its 30-day fair value range of $27.97 to $32.47.
Technical Outlook: Technically, BEAM is in a uptrend. Immediate support is located at $28.67, while resistance sits at $36.88. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: BEAM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $51.07 (+43.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BEAM is in a uptrend. Immediate support is located at $28.67, while resistance sits at $36.88. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: BEAM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $51.07 (+43.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$27.97 -
$32.47
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
Protect Your Profits
Holding BEAM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 43.7% below Wall St target ($51.07)
- CAUTION: Extended 9.4% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$27.97 -
$32.47
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$28.67
Resistance Level
$36.88
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.49
Wall Street Target
$51.07
(+43.7%)
Revenue Growth (YoY)
324.9%
Profit Margin
-40.2%
Share & Embed Analysis
Last updated: June 23, 2026 8:37 AM ET
Data refreshes hourly during market hours. Next update: 9:37 AM
Data refreshes hourly during market hours. Next update: 9:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BEAM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Amy Simon
SELL
6700 shares
2026-04-01
Christine Bellon
SELL
5956 shares
2026-04-01
Giuseppe Ciaramella
SELL
11810 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 55 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 69 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 58 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced BEAM Option Strategies
Professional options setups generated by AI based on today's BEAM price and gamma walls.
